Immunogenicity of Investigational 2-Dose Hepatitis B Vaccine, HEPLISAV-B, Compared With a Licensed Vaccine (ENGERIX-B) in Adults With Factors That Reduce Immune Responses
Open Forum Infectious Diseases（2016）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要